Why Is Nivestym So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed Nivestym (filgrastim-aafi) and you're struggling to fill the prescription, you're not alone. Unlike common medications stocked at every corner pharmacy, Nivestym is a specialty biologic that moves through a very different supply chain — and that makes it harder to find on a given day.

In this guide, we'll explain exactly why Nivestym availability can be inconsistent, what factors affect supply, and what you can do right now to find it near you.

What Is Nivestym and Why Is It Prescribed?

Nivestym is a biosimilar to Neupogen (filgrastim), a granulocyte colony-stimulating factor (G-CSF). It was FDA-approved on July 20, 2018, and is manufactured by Pfizer. G-CSF medications like Nivestym work by stimulating the bone marrow to produce more neutrophils — white blood cells that fight bacterial and fungal infections.

It is most commonly prescribed for:

• Patients with cancer receiving myelosuppressive chemotherapy that puts them at risk for febrile neutropenia
• Patients with acute myeloid leukemia (AML) undergoing induction or consolidation chemotherapy
• Patients undergoing bone marrow transplantation (BMT)
• Patients requiring peripheral blood progenitor cell (PBPC) mobilization for stem cell transplants
• Patients with severe chronic neutropenia (congenital, cyclic, or idiopathic)

Because Nivestym is used to prevent life-threatening infections in cancer patients, not being able to fill it quickly is a serious problem.

Why Is Nivestym Difficult to Find at Regular Pharmacies?

The short answer: Nivestym is a specialty biologic, not a standard tablet or capsule. This affects nearly every aspect of how it's stored, distributed, and dispensed.

1. Nivestym Requires Cold Chain Storage

Nivestym must be stored refrigerated at 2°C to 8°C (36°F to 46°F). It can only be left at room temperature for up to 24 hours before it must be discarded. This cold chain requirement means most retail pharmacies don't stock it regularly — they only order it when a patient presents a prescription. If your pharmacy hasn't ordered it recently, they may be out of stock or have limited supply.

2. It's a Specialty Medication Distributed Through Specialty Channels

Many insurers require Nivestym to be dispensed through specialty pharmacies rather than retail chains. Specialty pharmacies (such as those affiliated with cancer centers or hospital systems) stock these medications in greater quantities, but they may not be located near every patient. If your prescription was sent to a retail pharmacy, it may not be available there at all.

3. Prior Authorization Causes Delays

Insurance plans typically require prior authorization (PA) before covering Nivestym. The PA process involves your prescriber documenting your diagnosis, previous treatments, and why Nivestym is medically necessary. This process can take days, causing delays even when supply is adequate. In the meantime, you may be unable to pick up the medication.

4. Multiple Competing Biosimilars Mean Variable Pharmacy Stock

Nivestym competes with several other G-CSF products including Neupogen, Zarxio (filgrastim-sndz), Releuko (filgrastim-ayow), Nypozi (filgrastim-txid), and Granix (tbo-filgrastim). Because pharmacies can't stock all of these in depth, they tend to keep only one or two filgrastim products on hand. If Nivestym is specifically prescribed, pharmacies stocking a competing biosimilar may not have yours available.

5. Demand Spikes from Cancer Treatment Cycles

Chemotherapy is typically given in cycles. Because many patients in an area may be on similar treatment schedules, pharmacies serving oncology clinics can experience surges in demand around cycle dates. This predictable but sudden demand can temporarily deplete local pharmacy inventory.

Is There a Nivestym Shortage in 2026?

As of 2026, Nivestym is not listed on the FDA's official drug shortage list. However, "no active shortage" does not mean "easy to find at any pharmacy." Nivestym's specialty nature means availability is inherently localized — stocking levels vary from pharmacy to pharmacy, city to city.

The challenge for most patients isn't a national supply crisis — it's finding which local pharmacy actually has it in stock right now.

What Can You Do to Find Nivestym in Stock?

Here are practical steps you can take right now:

1. Ask your oncology team first. Cancer centers and infusion clinics often stock or dispense Nivestym directly. Your care team may be able to give you a dose on-site or help coordinate with their pharmacy.
2. Contact specialty pharmacies. Pharmacies like CVS Specialty, Walgreens Specialty, Accredo, or your cancer center's own pharmacy are more likely to stock Nivestym.
3. Use medfinder.
4. Ask about alternative biosimilars. If Nivestym specifically isn't available, your doctor may be able to switch your prescription to Zarxio, Releuko, or another filgrastim product with similar efficacy. See our guide to how to find Nivestym in stock near you for more options.
5. Start the PA process immediately. If prior authorization is holding up your prescription, ask your oncologist's office to submit an urgent PA request. Some insurers have expedited reviews for medically urgent situations.

How medfinder Helps

medfinder is a service that calls pharmacies near you to check which ones can fill your Nivestym prescription — so you don't have to spend hours on the phone yourself. You simply provide your medication, dosage, and location, and medfinder does the calling. Results are texted to you. Visit medfinder.com to get started.

The Bottom Line

Nivestym is hard to find not because of a national shortage, but because it's a specialty biologic with cold-chain requirements, insurance barriers, and limited retail distribution. The good news is that once you know the right channels to use — specialty pharmacies, your oncology team, or services like medfinder — finding it becomes much more manageable. If all else fails, ask your doctor about Nivestym alternatives that may be more readily available near you.